Voloridge Investment Management
TIL icon

Voloridge Investment Management’s Instil Bio TIL Stock Holding History

Voloridge Investment Management’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-3,793
Closed -$350K – 1618
2022
Q2 		$350K Buy
+3,793
New +$537K ﹤0.01% 1338

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Voloridge Investment Management's TIL Position: Q3 2022 in Review

Voloridge Investment Management sold out of Instil Bio (TIL) in Q3 2022, closing a stake of 3,793 shares — an estimated $350K sold.

Voloridge Investment Management first reported a position in TIL in Q2 2022 and held it in 1 quarter. The position peaked at $350K in Q2 2022. 95 funds tracked by Wall St. Rank hold TIL as of Q3 2022.

  • Voloridge Investment Management reported no remaining Instil Bio position as of Q3 2022 after selling out during the quarter.
  • Voloridge Investment Management sold 3,793 Instil Bio shares in Q3 2022, an estimated $350K.
  • Voloridge Investment Management first reported a position in Instil Bio in Q2 2022 and held it in 1 quarter.
  • Voloridge Investment Management's Instil Bio position peaked at $350K in Q2 2022.
  • 95 funds tracked by Wall St. Rank held Instil Bio as of Q3 2022.

Based on Voloridge Investment Management's 13F filing for Q3 2022, filed 14 Nov 2022.